Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingdan Chen

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
International Journal of Cardiology|February 19, 2018
VEGF165b elevation in pulmonary arterial hypertension patients, causative or adaptive?Lingdan Chen, Mingjie Yuan, Tao Wang
International Journal of Cardiology|September 17, 2017
MicroRNA-93 upregulation in coronary artery disease is potentially adaptiveTao Lin, Mingjie Yuan, Lingdan Chen, et al.
International Journal of Cardiology|February 18, 2020
Stroke in pulmonary hypertension: Is it predictable or preventable?Lingdan Chen, Wenjun He, Fei Liu, et al.
Medical Hypotheses|August 19, 2017
MicroRNA-93 elevation after myocardial infarction is cardiac protectiveKai Li, Tao Lin, Lingdan Chen, et al.
American Journal of Respiratory and Critical Care Medicine|February 8, 2020
BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?Lingdan Chen, Chunli Liu, Wenju Lu, et al.
International Journal of Cardiology|May 20, 2018
Can treprostinil-induced early gastrointestinal side effects serve as predictors of pulmonary arterial hypertension prognosis?Tao Wang, Lingdan Chen, Mingjie Yuan, et al.
Experimental Physiology|September 27, 2024
Establishment of mouse models for severe pulmonary hypertension through 'double-hit' strategiesLingdan Chen, Xin Chen, Yuhang Huang, et al.
International Journal of Cardiology|July 26, 2018
Modulation of EPC: A new hope for pulmonary artery hypertension treatmentTao Wang, Cheng Hong, Lingdan Chen, et al.
Bioscience Reports|January 24, 2018
The roles of interleukins in perfusion recovery after peripheral arterial diseaseLingdan Chen, Hanwei Liu, Mingjie Yuan, et al.
International Journal of Cardiology|July 26, 2018
Macrophage migration inhibitory factor (MIF) elevation in acute myocardial infarction is arteriogenicBin Peng, Lingdan Chen, Kai Li, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
International Journal of Cardiology|February 19, 2018
VEGF165b elevation in pulmonary arterial hypertension patients, causative or adaptive?Lingdan Chen, Mingjie Yuan, Tao Wang
International Journal of Cardiology|September 17, 2017
MicroRNA-93 upregulation in coronary artery disease is potentially adaptiveTao Lin, Mingjie Yuan, Lingdan Chen, et al.
International Journal of Cardiology|February 18, 2020
Stroke in pulmonary hypertension: Is it predictable or preventable?Lingdan Chen, Wenjun He, Fei Liu, et al.
Medical Hypotheses|August 19, 2017
MicroRNA-93 elevation after myocardial infarction is cardiac protectiveKai Li, Tao Lin, Lingdan Chen, et al.
American Journal of Respiratory and Critical Care Medicine|February 8, 2020
BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?Lingdan Chen, Chunli Liu, Wenju Lu, et al.
International Journal of Cardiology|May 20, 2018
Can treprostinil-induced early gastrointestinal side effects serve as predictors of pulmonary arterial hypertension prognosis?Tao Wang, Lingdan Chen, Mingjie Yuan, et al.
Experimental Physiology|September 27, 2024
Establishment of mouse models for severe pulmonary hypertension through 'double-hit' strategiesLingdan Chen, Xin Chen, Yuhang Huang, et al.
International Journal of Cardiology|July 26, 2018
Modulation of EPC: A new hope for pulmonary artery hypertension treatmentTao Wang, Cheng Hong, Lingdan Chen, et al.
Bioscience Reports|January 24, 2018
The roles of interleukins in perfusion recovery after peripheral arterial diseaseLingdan Chen, Hanwei Liu, Mingjie Yuan, et al.
International Journal of Cardiology|July 26, 2018
Macrophage migration inhibitory factor (MIF) elevation in acute myocardial infarction is arteriogenicBin Peng, Lingdan Chen, Kai Li, et al.
Pageof 4